Oncternal Therapeutics, Inc.·4

Sep 2, 4:53 PM ET

CARTER MICHAEL G 4

4 · Oncternal Therapeutics, Inc. · Filed Sep 2, 2020

Insider Transaction Report

Form 4
Period: 2020-09-01
Transactions
  • Purchase

    Common Stock

    2020-09-01$2.10/sh+71,429$150,00171,947 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION